Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence

Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence

One of the great challenges of postoperative prostate cancer management is tumor recurrence. Although postoperative chemotherapy presents benefits to inhibit unexpected recurrence, it is still limited due to the drug resistance or intolerable complications of some patients. Electrospun nanofiber, as...

Full description

Bibliographic Details
Main Authors: Zheng Liu, Xing Luo, Yongxin Mo, Pengkai Zhao, Haixia Wang, Youqiang Fang, Yanteng Xu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceuticals
Subjects:
electrospun fiber
DOX
Bcl-2
ABT199
prostate cancer
tumor recurrence
Online Access:https://www.mdpi.com/1424-8247/15/10/1244

Similar Items

Similar Items